NABRIVA THERAPEUTICS PLC (NBRV)
IE000OZRGNV6 - Common Stock
| TTM (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -54.07M | -57.19M | -49.45M | -69.48M | -82.76M | |||
| Depreciation Amortization | 160.00K | 217.00K | 356.00K | 420.00K | 400.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | 0.00 | |||
| Change In Working Capital | 20.82M | 13.73M | -14.86M | -11.39M | -200.00K | |||
| Interest Paid | 445.00K | 406.00K | 497.00K | 1.40M | 2.56M | |||
| Taxes Paid | 999.00K | 1.00M | 513.00K | 0.00 | 10.00K | |||
| Other non cash items | 6.62M | 6.52M | 4.39M | 9.13M | 10.67M | |||
| OPERATING CASH FLOW | -26.46M | -36.71M | -59.56M | -71.33M | -71.89M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -179.00K | -211.00K | -25.00K | -110.00K | -60.00K | |||
| Other Investing Activity | -51.00K | -52.00K | -56.00K | -160.00K | 390.00K | |||
| INVESTING CASH FLOW | -230.00K | -263.00K | -81.00K | -270.00K | 330.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -7.77M | -2.92M | 0.00 | -30.00M | 9.98M | |||
| Stock Issued/Repurchased | 2.94M | 5.18M | 70.19M | 61.65M | 48.08M | |||
| Other Financing Activity | -360.00K | -405.00K | -3.83M | -4.72M | -1.99M | |||
| FINANCING CASH FLOW | -5.20M | 1.85M | 66.37M | 26.92M | 56.08M | |||
| Exchange Rate Effect | -153.00K | -174.00K | -484.00K | -140.00K | -110.00K | |||
| CHANGE IN CASH | -32.04M | -35.30M | 6.24M | -44.82M | -15.59M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -26.46M | -36.71M | -59.56M | -71.33M | -71.89M | |||
| Capital Expenditure | -179.00K | -211.00K | -25.00K | -110.00K | -60.00K | |||
| FREE CASH FLOW | -26.64M | -36.92M | -59.58M | -71.44M | -71.95M | |||
All data in USD